Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000851829 | SCV005061702 | uncertain significance | Glanzmann thrombasthenia | 2024-06-06 | reviewed by expert panel | curation | The c.574+5G>A variant in ITGA2B is an intronic variant in intron 4. This variant has been detected in the homozygous form in at least 1 proband in the ThromboGenetics cohort (TGP0375, PMID:31064749) Total points: 0.5 (PM3_Supporting). TGP0375 was not reported with supporting phenotypic information and did not meet criteria for PP4 (PMID:31064749).This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational splicing predictor SpliceAI gives a score of 0.8 for donor loss, predicting that the variant disrupts the donor splice site of intron 4 (PP3). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PM2_Supporting, PP3, PM3_supporting. (VCEP specifications version 2; date of approval 06/06/2024) |
NIHR Bioresource Rare Diseases, |
RCV000851829 | SCV000899813 | likely pathogenic | Glanzmann thrombasthenia | 2019-02-01 | criteria provided, single submitter | research |